The Dilemma of Mild Hypertension

Moser, Marvin; Black, Henry R.; Stair, David C.

doi:10.2165/00003495-198631040-00001

Cited by 14 publications

(3 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An incorrect diagnosis of hypertension resulting from improper technique can have lifelong social, economic and medical implications for the patient (O'Brien & O'Malley 1988). Alternatively, failing to diagnose and treat adequately high blood pressure will deprive patients of the documented benefits of antihypertensive therapy (Moser et al 1986). A correct diagnosis leading to the appropriate treatment of hypertension is based on accurate measurement of blood pressure.…”

Section: Introductionmentioning

confidence: 99%

Assessment of blood pressure measuring techniques

1992

View full text Add to dashboard Cite

The recommended techniques to measure blood pressure for assessment of hypertension are seldom followed in the ambulatory care setting. This study has found that interns and first-year family practice residents have significant deficits in their knowledge and use of the recommended techniques to measure blood pressure. The results suggest that inadequacies exist in the teaching of blood pressure measuring techniques in our medical schools, the consequences of which are misdiagnosis and improper treatment of high blood pressure.

show abstract

Section: Introductionmentioning

confidence: 99%

Assessment of blood pressure measuring techniques

1992

View full text Add to dashboard Cite

show abstract

“…A decrease in serum potassium of 0.6 mmol 1 1 is common with long term diuretic use (Morgan & Davidson, 1980). Some authorities however (Freis, 1986;Moser et al, 1986) do not agree with the above view that diuretic induced metabolic changes are dangerous.…”

Section: Introductionmentioning

confidence: 99%

Metabolic and endocrine consequences of calcium channel blockade

Feely

Cullen

Collins

1986

Brit J Clinical Pharma

View full text Add to dashboard Cite

It has been suggested that the adverse metabolic effects of thiazide and β‐adrenoceptor blockers may explain their failure to alter significantly the death rate from coronary heart disease in hypertensive patients. Because of their increasing use, the metabolic effects of calcium antagonists are of importance. Although there are a number of case reports of hyperglycaemia with nifedipine, larger studies with it and nicardipine in diabetics do not show significant deterioration in diabetic control. Neither nicardipine nor nifedipine appear to alter total cholesterol or urate levels and hypokalaemia has not been reported. While verapamil may acutely alter pituitary function, more detailed studies with nicardipine and nifedipine have found no significant effect on pituitary or thyroid function. To date the dihydropyridine calcium antagonists, nicardipine and nifedipine, appear remarkably free of adverse metabolic or endocrine effects.

show abstract

“…However, in the late 1970s and early 1980s the generally accepted policy of blood pressure reduction was shaken by the relatively small benefits found in large intervention trials (9-13). Since then there has been a widespread discussion, especially whether we should treat milder forms of arterial hypertension or not ( [14][15][16][17][18][19][20]. Although the medical and statistical factual background has been extensively debated, only a few papers explored the ethical and moral consequences of various intervention approaches (21-25).…”

mentioning

confidence: 99%